NEW YORK (GenomeWeb News) – Bruker announced today an agreement to acquire the preclinical in vivo imaging equipment product portfolio and related assets from Carestream Health's Molecular Imaging business for an undisclosed amount.

The deal is expected to be completed in the next several weeks, Bruker said. The majority of employees in the Carestream business being bought by Bruker are being offered employment with Bruker.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.